Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon.
A small number of patients with haemangioma need treatment for serious complications such as Kasabach-Merritt syndrome, cardiac failure and obstruction of the airway. We report on the management of an infant with Kasabach-Merritt syndrome.
Ettlinger
J J
JJ
Department of Neonatal and Intensive Care Medicine, Royal Hospital for Sick Children, Bristol, England.
Fleming
P J
PJ
Joffe
H S
HS
Kennedy
C T
CT
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000628:therapy*; D006392:Hemangioma, Cavernous / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D013577:Syndrome; D013921:Thrombocytopenia / Q000628:therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha